Table 1. Colombian mutations (besides Presenilin 1 E280A, Presenilin 1 I416T, and APOE3ch).
| Mutation | State or department | Phenotype | Age of onset (years) |
|---|---|---|---|
| APP Gly708 | Cundinamarca | Silent mutation, but the proband had sporadic Alzheimer’s disease | 71 |
| PSEN1 Val94Met | Cundinamarca | Sporadic Alzheimer’s disease | 53 |
| PSEN1 Ile143Thr | Cundinamarca | Autosomal dominant Alzheimer’s disease | 30 |
| PSEN 1 Glu318Gly | Cundinamarca | Sporadic and familial cases (the mutation is a risk modifier) | 65.8 (49-86) |
| PSEN1 Pro117Ala | Valle del Cauca | Autosomal dominant Alzheimer’s disease | Fourth decade of life |
| PSEN2 Pro129 | Cundinamarca | Silent mutation, but the proband had autosomal dominant Alzheimer’s disease | 62 |
| PSEN2 Ser236 | Cundinamarca | Silent mutation, but the probands had sporadic Alzheimer’s disease | 83.2 (78-88) |
| TREM2 Trp198X | Antioquia | PLOSL and early-onset dementia (autosomal recessive) | FTD-like syndrome, at 47 |
PSEN1: Presenilin 1; PSEN2: Presenilin 2; APP: amyloid precursor protein; PLOSL: polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy; TREM2: triggering receptor expressed on myeloid cells 2; FTD: frontotemporal dementia.